Matthew Shepard

Matthew Shepard practices at Saint Francis Medical Center in Cape Girardeau, Missouri, part of Saint Francis Healthcare System.

Matthew Shepard's NPI, 1205988573, was assigned on January 17, 2007. Matthew Shepard graduated from Indiana University School of Medicine in 1994. Matthew Shepard holds Missouri license 113520.

Matthew Shepard's primary practice is Saint Francis Medical Center, at 211 St Francis Dr, Cape Girardeau, MO 63703 in Cape Girardeau County. The practice phone is (573) 331-3000.

Matthew Shepard's primary practice is Saint Francis Medical Center in Cape Girardeau, Missouri, part of Saint Francis Healthcare System. Matthew Shepard is also affiliated with Mercy Hospital Southeast. The medical group on file is Saint Francis Medical Center. Dmand AI also links Matthew Shepard to 1 more hospital, named with a free account. Matthew Shepard's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Shepard practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Matthew Shepard's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Matthew Shepard is licensed in Missouri.

CMS data shows 767 Medicare services from Matthew Shepard across 8 procedure codes in 2024, for 273 Medicare patients. Medicare paid $61,858 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 273 Medicare patients who saw Matthew Shepard in 2024. The largest group is 75 to 84, with 111 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Matthew Shepard's median patient age at 73, with 53% women.

In 2024, Matthew Shepard wrote 394 Medicare Part D claims for 108 patients. 81% of them were for generic drugs. CMS names the drug for 143 of them, across 8 drugs with 11 or more claims each, at $10,442 in total drug cost. In 2023, CMS named 330 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 67 out of 100 for Matthew Shepard for performance year 2024, reported through an alternative payment model (APM). Matthew Shepard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 146 general payments to Matthew Shepard from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $733.

Matthew Shepard graduated from Indiana University School of Medicine in 1994.